Methylated host cell gene promoters and human papillomavirus type 16 and 18 predicting cervical lesions and cancer

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Milutin Gašperov, Nina ^a   Sabol, Ivan ^a   Planinić, Pavao ^b   Grubišić, Goran ^c   Fistoniæ, Ivan ^d   Ćorušić, Ante ^b   Grce, Magdalena ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC Zagreb   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Private Gynaecological Clinic   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; UVOMORULIN; CYTOSINE; VIRUS DNA;

ARTICLE; C13ORF18 GENE; CCNA1 GENE; CDH1 GENE; CONTROLLED STUDY; CPG ISLAND; DAPK1 GENE; DNA METHYLATION; FEMALE; GENE FREQUENCY; HIC1 GENE; HOST CELL; HTERT1 GENE; HTERT2 GENE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; ONCOGENE; PROGNOSIS; PROMOTER REGION; RARBETA2 GENE; SEQUENCE ANALYSIS; TWIST1 GENE; UTERINE CERVIX CANCER; UTERUS DISEASE; VIRUS GENOME; ADULT; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; BIOMARKERS; CELL LINE; CERVIX UTERI; CPG ISLANDS; CYTOSINE; DNA METHYLATION; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84936874063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129452     Document Type: Article

References (47)

1. De Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11: 1048-1056. doi: 10.1016/S1470-2045(10)70230-8 PMID: 20952254
2. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res. 2001; 7: 584-589. PMID: 11297252
3. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002; 21: 5400-5413. doi: 10.1038/sj.onc.1205651 PMID: 12154403
4. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16: 6-21. doi: 10.1101/gad.947102 PMID: 11782440
5. Burchell AN, Rodrigues A, Moravan V, Tellier P-P, Hanley J, Coutlée F, et al. Determinants of prevalent human papillomavirus in recently-formed heterosexual partnerships: A dyadic-level analysis. J Infect Dis. 2014; doi: 10.1093/infdis/jiu200
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007; 370: 890-907. doi: 10.1016/S0140-6736(07)61416-0 PMID: 17826171
7. Steenbergen RDM, Kramer D, Braakhuis BJM, Stern PL, Verheijen RHM, Meijer CJLM, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst. 2004; 96: 294-305. PMID: 14970278
8. Remus R, Ka¨mmer C, Heller H, Schmitz B, Schell G, Doerfler W. Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J Virol. 1999; 73: 1010-1022. PMID: 9882302
9. Badal V, Chuang LSH, Tan EH-H, Badal S, Villa LL, Wheeler CM, et al. CpG Methylation of Human Papillomavirus Type 16 DNA in Cervical Cancer Cell Lines and in Clinical Specimens: Genomic Hypomethylation Correlates with Carcinogenic Progression. J Virol. 2003; 77: 6227-6234. doi: 10.1128/JVI.77.11.6227-6234.2003 PMID: 12743279
10. Woodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007; 7: 11-22. doi: 10.1038/nrc2050 PMID: 17186016
11. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol. 2009; 112: 293-299. doi: 10.1016/j.ygyno.2008.10.012 PMID: 19054549
12. De Wilde J, Kooter J, Overmeer R, Claassen-Kramer D, Meijer C, Snijders P, et al. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis. BMC Cancer. 2010; 10: 271. doi: 10.1186/1471-2407-10-271 PMID: 20534141
13. Yang N, Eijsink JJH, Lendvai A, Volders HH, Klip H, Buikema HJ, et al. Methylation Markers for CCNA1 and C13ORF18 Are Strongly Associated with High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in Cervical Scrapings. Cancer Epidemiol Biomarkers Prev. 2009; 18: 3000-3007. doi: 10.1158/1055-9965.EPI-09-0405 PMID: 19843677
14. Eijsink JJH, Yang N, Lendvai A, Klip HG, Volders HH, Buikema HJ, et al. Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol. 2011; 120: 280-283. doi: 10.1016/j.ygyno.2010.10.029 PMID: 21093897
15. Sun C, Reimers LL, Burk RD. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol. 2011;
16. Patel DA, Rozek LS, Colacino JA, Van Zomeren-Dohm A, Ruffin MT, Unger ER, et al. Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. J Virol Methods. 2012; 184: 84-92. doi: 10.1016/j.jviromet.2012.05.022 PMID: 22664184
17. Kalantari M, Osann K, Calleja-Macias IE, Kim S, Yan B, Jordan S, et al. Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia. Virology. 2014; 448: 314-321. doi: 10.1016/j.virol.2013.10.032 PMID: 24314662
18. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, et al. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer. 2006; 6: 55. PMID: 16524460
19. Dessain SK, Yu H, Reddel RR, Beijersbergen RL, Weinberg RA. Methylation of the human telomerase gene CpG island. Cancer Res. 2000; 60: 537. PMID: 10676632
20. Ivanova T, Petrenko A, Gritsko T, Vinokourova S, Eshilev E, Kobzeva V, et al. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer. 2002; 2: 4. PMID: 11945179
21. Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, et al. Folate Status and Aberrant DNA Methylation Are Associated With HPV Infection and Cervical Pathogenesis. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2782-2789. doi: 10.1158/1055-9965.EPI-09-0493 PMID: 19755648
22. Iliopoulos D, Oikonomou P, Messinis I, Tsezou A. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Oncol Rep. 2009; 22: 199-204. PMID: 19513524
23. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005; 97: 273-282. PMID: 15713962
24. Ovanin-Rakić A, Pajtler M, Stanković T, Audy-Jurkoví S, Ljubojević N, Grubišič G, et al. The classification of cytologic findings of cervix uteri "Zagreb 2002": The Modification of the "Zagreb 1990" and "NCI Bethesda System 2001" Classifications. Gynaecol Perinatol. 2003; 12: 148-153.
25. Kumari A, Srinivasan R, Wig JD. Effect of c-MYC and E2F1 Gene Silencing and of 5-Azacytidine Treatment on Telomerase Activity in Pancreatic Cancer-Derived Cell Lines. Pancreatology. 2009; 9: 360-368. doi: 10.1159/000212094 PMID: 19451745
26. Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 2007; 67: 194-201. doi: 10.1158/0008-5472.CAN-06-3396 PMID: 17210699
27. Dueñas-González A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer. 2005; 4: 38. doi: 10.1186/1476-4598-4-38 PMID: 16248899
28. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer. 2003; 2: 24. PMID: 12773202
29. Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, et al. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res. 2004; 10: 3396-3400. PMID: 15161694
30. Farkas SA, Milutin-Gašperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics. 2013; 8: 1213-1225. doi: 10.4161/epi.26346 PMID: 24030264
31. Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU. Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology. 2008; 374: 292-303. doi: 10.1016/j.virol.2007.12.016 PMID: 18242658
32. Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer. 2013; 132: 1412-1422. doi: 10.1002/ijc.27750 PMID: 22847263
33. Lorincz AT, Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Castanon A, Fiander A, et al. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology: HPV16 DNA methylation in cervical lesions. Int J Cancer. 2013; 133: 637-644. doi: 10.1002/ijc.28050 PMID: 23335178
34. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol. 2004; 78: 12762. PMID: 15542628
35. Bhattacharjee B, Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology. 2006; 354: 280-285. PMID: 16905170
36. Matovina M, Sabol I, Grubisic G, Gasperov N, Grce M. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol. 2009; 113: 120-127. doi: 10.1016/j.ygyno.2008.12.004 PMID: 19157528
37. Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology. 2007; 361: 185-193. PMID: 17175003
38. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, et al. Methylation of the human papillomavirus-18 L1 gene: A biomarker of neoplastic progression? Virology. 2006; 349: 175-183. PMID: 16472835
39. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LSH, Li BFL, et al. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology. 2004; 324: 483-492. PMID: 15207633
40. Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, et al. Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21: 2125-2137. doi: 10.1158/1055-9965.EPI-12-0905 PMID: 23035178
41. Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, et al. Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3. JNCI J Natl Cancer Inst. 2012; 104: 1738-1749. doi: 10.1093/jnci/djs425 PMID: 23093560
42. Cuzick J, Bergeron C, von Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, et al. New Technologies and Procedures for Cervical Cancer Screening. Vaccine. 2012; 30: F107-F116. doi: 10.1016/j.vaccine.2012.05.088 PMID: 23199953
43. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004; 429: 457-463. doi: 10.1038/nature02625 PMID: 15164071
44. Vrdoljak E, Haller H, Corusić A, Jelavić TB, Matković V, Strinić T, et al. [Clinical recommendations for diagnosing, treatment and monitoring of patients with uterine cervical cancer-Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology]. Liječnički Vjesn. 2013; 135: 225-229.
45. Sambrook J, Frisch EF, Maniatis T. Molecular cloning - A laboratory manual. 2nd edn. Cold Sprind Harbor Laboratory, Cold Spring Harbor, New York; 1982.
46. Milutin-Gasperov N, Sabol I, Halec G, Matovina M, Grce M. Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women. Coll Antropol. 2007; 31 Suppl 2: 89-96. PMID: 17598510
47. Yang HJ, Liu V, Wang Y, Tsang P, Ngan H. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer. 2006; 6: 212. PMID: 16928264